MDS Congress 2025 Session Evaluation

MDS Congress 2025 Session 4206 Evaluation Form
Plenary Session 4206

Disease-Modifying Trials for Parkinson’s Disease: Past, Present, and Future

October 8, 2025

10:00 - 11:30
Learning Objectives:

1. Discuss recent and ongoing or in development trials for disease modification in Parkinson's disease
2. Discuss challenges in patient selection including biomarkers and recruitment of prodromal subjects
3. Discuss the importance of improving outcome measures including multi-arm multi-stage trial design, remote monitoring and digital technologies
Session Evaluation
The session met its learning objectives

Strongly agreeAgreeDisagreeStrongly disagree
The content is relevant to my professional and / or scientific interests.

Strongly agreeAgreeDisagreeStrongly disagree
The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.

Strongly agreeAgreeDisagreeStrongly disagree
The overall session organization was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
I would recommend this session to a colleague.

Strongly agreeAgreeDisagreeStrongly disagree
Faculty Assessment
Tatyana Simuni, USA
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Camille Carroll, United Kingdom
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Jean-Christophe Corvol, France
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
How would you improve this activity?
Please provide any additional comments
The following category best describes your current major professional activity (choose one):

Patient managementBasic Science researchClinical ResearchTeachingResident/PhD StudentUndergraduate StudentOther
My country:
Should be Empty:

MDS Congress 2025 Session 4206 Evaluation Form

Plenary Session 4206

Disease-Modifying Trials for Parkinson’s Disease: Past, Present, and Future